Results 1 to 10 of about 239,209 (258)
Thoracic Surgery Clinics, 2020 Five-year survival rates for patients with early-stage non-small cell lung cancer have room for improvement. Adjuvant chemotherapy results in a small but significant increase in overall survival at 5 years. Efforts to improve outcomes by intensifying adjuvant treatment, utilizing cancer-specific vaccines or tyrosine kinase inhibitors in unselected ...
Jessica A, Hellyer, Heather A, Wakelee
+5 more sources
Chemotherapy adjuvant and chemotherapy-induced neutropenia
Taiwanese Journal of Obstetrics & Gynecology, 2022 Yiu-Tai Li, Szu-Ting Yang, Peng-Hui Wang
doaj +3 more sources
Surgical Clinics of North America, 1986 At present, adjuvant chemotherapy exerts no significant impact on long-term survival and only occasionally provides brief palliation in head and neck cancer. The major contribution of chemotherapy has been in the preoperative period, when therapy for advanced squamous cell carcinoma may render some patients candidates for curative operations or ...
C K, Osborne, C A, Coltman
openaire +4 more sources
Clinical efficacy of adjuvant chemotherapy in stage IB (< 4 cm) non-small cell lung cancer patients with high-risk factors [PDF]
The Korean Journal of Internal Medicine, 2022 Background/Aims Adjuvant chemotherapy is the standard of care for resected stage II–IIIA non-small cell lung cancer (NCSLC). The efficacy of adjuvant chemotherapy in stage IB (< 4 cm) NSCLC with high-risk factors is controversial.
Juwhan Choi +12 more
doaj +1 more source
Annals of Gastroenterological Surgery, 2023 Aim We aimed to clarify the use of adjuvant chemotherapy and the prognosis of elderly colorectal cancer patients compared with non‐elderly patients, and the usefulness of sarcopenia as an indicator for the introduction and completion of adjuvant ...
Takuya Shiraishi +8 more
doaj +1 more source
Novel molecular classification of endometrial cancer - current and future clinical implications [PDF]
Vojnosanitetski Pregled, 2023 nema
Mandić Aljoša +4 more
doaj +1 more source
Update on Adjuvant Treatment in Resectable Non-Small Cell Lung Cancer and Potential Biomarkers Predicting Postoperative Relapse [PDF]
Tuberculosis and Respiratory Diseases, 2023 A significant proportion of patients with non-small cell lung cancer (NSCLC) is diagnosed in the early and resectable stage. Despite the use of platinum-based adjuvant chemotherapy, there was only a marginal increase in overall survival and a 15 ...
Jeong Uk Lim
doaj +1 more source
Adjuvant chemotherapy for elderly patients with gastric cancer after D2 gastrectomy. [PDF]
PLoS ONE, 2013 BACKGROUND: A phase III clinical trial has already shown the survival benefits of postoperative chemotherapy in gastric cancer. However, there are limited published data concerning the elderly.
Ying Jin +10 more
doaj +1 more source
Scientific Reports, 2022 Concurrent chemoradiotherapy is the established treatment for locally advanced nasopharyngeal carcinoma (NPC). However, there is no evidence supporting routine adjuvant chemotherapy. We aimed to demonstrate the effect of adjuvant chemotherapy on survival
Mu-Hung Tsai +5 more
doaj +1 more source
Frontiers in Oncology, 2022 BackgroundFor rectal cancer, it remains unclear how to incorporate tumor response to neoadjuvant chemoradiotherapy (nCRT) when deciding whether to give adjuvant chemotherapy.
Yu-Hsuan Kuo +12 more
doaj +1 more source